Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT. Altheia Science’s pipeline exploits pioneering therapeutic tools for autoimmune diseases and cancer. The modulation of PD-L1 expression at the molecular and protein level is key to devise advanced treatments. This can be achieved by first-in-class molecules controlling the PD-L1 pathway and/or by lentiviral vector-based engineering of patients’ hematopoietic stem cells. Altheia Science’s approach intends to drastically modify the natural history of diseases with high clinical impact in autoimmunity and cancer by modulating PD-L1 expression, achieving tangible and durable benefit for each patient.
Company Details
- Employees
- 5
- Founded
- 2017
- Address
- Via Enrico Besana, 7, Milano,lombardia 20122,italy
- Phone
- +39 02 495 334 10
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- altheiascience.com
- Keywords
- biotechnology, gene therapy, advanced therapy medicinal products, autoimmunity, autoimmune diseases, type 1 diabetes, multiple sclerosis, cancer.
- HQ
- Milano, Lombardia
Altheia Science Questions
Altheia Science's helpline number is +39 02 495 334 10
Altheia Science's website is altheiascience.com
Altheia Science's LinkedIn profile is https://www.linkedin.com/company/altheia-science
Altheia Science has
5 employees.
View email and phone details for 5
employees at Altheia Science.
Altheia Science's industry is
Biotechnology Research
Altheia Science's top competitors are
Resalis Therapeutics,
Kither Biotech,
Alia Therapeutics,
Aurora-Tt,
Genenta Science (Nasdaq: Gnta),
Iama Therapeutics,
Sibylla Biotech,
Enthera Pharmaceuticals,
Cellply,
Molmed Now Part Of Agc Biologics.
Altheia Science's categories are Biotechnology Research
Altheia Science's founding year is 2017
